社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Moderna, Inc.(MRNA)
盘后
135.63
0.02
+0.01%
19:59 EDT
135.61
-4.72
-3.36%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Moderna, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.modernatx.com;www.investors.modernatx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。
09-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
09-01
关联方拟减持公告
Form 144 | Moderna, Inc. 高管 Klinger Shannon Thyme 拟减持3471股，市值约485,766.45美元
Form 144 | Moderna, Inc. 高管 Klinger Shannon Thyme 拟减持3471股，市值约485,766.45美元
08-12
超过5%披露
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
08-06
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
08-05
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
07-31
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07-31
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-24
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
07-15
关联方拟减持公告
Form 144 | Moderna高管Hoge Stephen拟减持53,336股，总价约360万美元
Form 144 | Moderna高管Hoge Stephen拟减持53,336股，总价约360万美元
07-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-18
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-15
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-04
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
05-21
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
05-15
关联方拟减持公告
Form 144 | Moderna, Inc. 高管 Stephen Hoge 拟减持53,336股普通股，拟套现约2,581,462.40美元
Form 144 | Moderna, Inc. 高管 Stephen Hoge 拟减持53,336股普通股，拟套现约2,581,462.40美元
分时
5日
日
周
月
数据加载中...
最高
143.94
今开
140.30
量比
0.53
最低
135.52
昨收
140.33
换手率
2.35%
热议股票
{"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"MRNA","data":{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":135.61,"timestamp":1788984000000,"preClose":140.33,"halted":0,"volume":8650474,"hourTrading":{"tag":"盘后","latestPrice":135.63,"preClose":135.61,"latestTime":"19:59 EDT","volume":300604,"amount":40766876.7721,"timestamp":1788998396741,"change":0.02,"changeRate":0.000147,"amplitude":0.003366},"delay":0,"changeRate":-0.033635003206726986,"floatShares":368045196,"shares":399235889,"eps":-8.007623,"marketStatus":"已收盘","change":-4.72,"latestTime":"09-09 16:00:00 EDT","open":140.295,"high":143.94,"low":135.52,"amount":1189969497.50406,"amplitude":0.060001,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.007623,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789027200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":140.33,"preHourTrading":{"tag":"盘前","latestPrice":140.17,"preClose":140.33,"latestTime":"09:29 EDT","volume":79930,"amount":11198744.516999999,"timestamp":1788960599999,"change":-0.16,"changeRate":-0.00114,"amplitude":0.011615},"postHourTrading":{"tag":"盘后","latestPrice":135.63,"preClose":135.61,"latestTime":"19:59 EDT","volume":300604,"amount":40766876.7721,"timestamp":1788998396741,"change":0.02,"changeRate":0.000147,"amplitude":0.003366},"volumeRatio":0.534241,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":false,"expireDate":1795150800000,"strike":"130.0","timestamp":1788971106251,"price":14.99,"volume":1400,"amount":2098600,"type":"+"},{"symbol":"MRNA","call":false,"expireDate":1789704000000,"strike":"130.0","timestamp":1788971106251,"price":2.69,"volume":1400,"amount":376600,"type":"-"}]},"impliedVol":0.7187,"impliedVolPercentile":0.2151},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21718984","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526378505-MRNA","pdf_url":"","pub_time":1788235200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/0001193125-26-378505-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896dex41.htm","primary":true,"translateUrl":"","linkName":"d108896dex41.htm","type":"EX-4.1","id":"NTFILE4Rgid6RBwWZQ8Xcp","market":"us","size":656222},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896d8k.htm","primary":false,"translateUrl":"","linkName":"d108896d8k.htm","type":"8-K","id":"NTFILECvca8cxLpCRogjVg","market":"us","size":56453},{"description":"EX-10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896dex101.htm","primary":false,"translateUrl":"","linkName":"d108896dex101.htm","type":"EX-10.1","id":"NTFILEBQ9ruF561AKdhf9f","market":"us","size":180174},{"description":"EX-99.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896dex991.htm","primary":false,"translateUrl":"","linkName":"d108896dex991.htm","type":"EX-99.1","id":"NTFILEDT7XXPQCuFxjEQgq","market":"us","size":12803},{"description":"EX-99.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896dex992.htm","primary":false,"translateUrl":"","linkName":"d108896dex992.htm","type":"EX-99.2","id":"NTFILE7k1LK2qRQspDhgm8","market":"us","size":17405},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp021.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp021.jpg","type":"GRAPHIC","id":"NTFILEFMniLTTCxzYhKSZz","market":"us","size":2312},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp022.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp022.jpg","type":"GRAPHIC","id":"NTFILE8y2MiGCWTBf1SFcV","market":"us","size":3814},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp023.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp023.jpg","type":"GRAPHIC","id":"NTFILEB7JgU1S2Rj1zZ2Pg","market":"us","size":3439},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp024.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp024.jpg","type":"GRAPHIC","id":"NTFILE7qjAhtSqYqztRJHR","market":"us","size":5197},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp039.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp039.jpg","type":"GRAPHIC","id":"NTFILE2hZzAcakKLbLLnDR","market":"us","size":3882},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/g108896dsp92.jpg","primary":false,"translateUrl":"","linkName":"g108896dsp92.jpg","type":"GRAPHIC","id":"NTFILEEsC6tJ7K8xecYnc9","market":"us","size":6590}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-09-01 12:00","pubTimestamp":1788235200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目1.01：签订实质性最终协议；项目2.03：设立注册人的直接财务义务或资产负债表外安排下的义务；第3.02项：未登记的股本证券销售；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21718040","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326006571-MRNA","pdf_url":"","pub_time":1788235200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna, Inc. 高管 Klinger Shannon Thyme 拟减持3471股，市值约485,766.45美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326006571/0001959173-26-006571-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna, Inc. 高管 Klinger Shannon Thyme 拟减持3471股，市值约485,766.45美元","gpt_en_title":"Form 144 | Moderna, Inc. Officer Klinger Shannon Thyme proposes to sell 3,471 shares with a total market value of about $485,766.45","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326006571/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8twNdTNRYuhsM4o5","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-09-01 12:00","pubTimestamp":1788235200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"21608394","market":"us","labels":[],"media":"sec.gov","original_id":"AN142284926000128-MRNA","pdf_url":"","pub_time":1786507200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"MRNA","title":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000142284926000128/0001422849-26-000128-index.htm","us_notice_code":"Form SCHEDULE 13G","us_title_en":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1422849/000142284926000128/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G","id":"NTFILE8Ce9asWuQui8eX93","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-08-12 12:00","pubTimestamp":1786507200,"title_zh":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21587918","market":"us","labels":[],"media":"sec.gov","original_id":"AN31506626002071-MRNA","pdf_url":"","pub_time":1786026825000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"MRNA","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/0000315066-26-002071-index.html","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/315066/000031506626002071/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILEG4ou3RCtJTz5KXTs","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-08-06 22:33","pubTimestamp":1786026825,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21579814","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326005661-MRNA","pdf_url":"","pub_time":1785902400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326005661/0001959173-26-005661-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1443340/000195917326005661/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8tFK9FfdG3A2FswZ","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-08-05 12:00","pubTimestamp":1785902400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21561216","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000150-MRNA","pdf_url":"","pub_time":1785470400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"MRNA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/0001682852-26-000150-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630.htm","primary":true,"translateUrl":"","linkName":"mrna-20260630.htm","type":"10-Q","id":"NTFILEFBHF1DRL6aoPv7Bz","market":"us","size":1474088},{"description":"EX-3.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/exhibit31arby-laws.htm","primary":false,"translateUrl":"","linkName":"exhibit31arby-laws.htm","type":"EX-3.1","id":"NTFILEGG4jwQxMfWXyRndm","market":"us","size":208457},{"description":"EX-31.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/exhibit31163026.htm","primary":false,"translateUrl":"","linkName":"exhibit31163026.htm","type":"EX-31.1","id":"NTFILEC7DshhQhqMgXGdAH","market":"us","size":9109},{"description":"EX-31.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/exhibit31263026.htm","primary":false,"translateUrl":"","linkName":"exhibit31263026.htm","type":"EX-31.2","id":"NTFILE474q7h5HMYqEobZy","market":"us","size":9049},{"description":"EX-32.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/exhibit32163026.htm","primary":false,"translateUrl":"","linkName":"exhibit32163026.htm","type":"EX-32.1","id":"NTFILEDnu2G1VTvoXzDU7x","market":"us","size":8266},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630_g1.jpg","primary":false,"translateUrl":"","linkName":"mrna-20260630_g1.jpg","type":"GRAPHIC","id":"NTFILE9woRT4Vjg3wVbKdS","market":"us","size":63925},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630_g2.jpg","primary":false,"translateUrl":"","linkName":"mrna-20260630_g2.jpg","type":"GRAPHIC","id":"NTFILEEzxL7dizadmY8zxn","market":"us","size":268063}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-07-31 12:00","pubTimestamp":1785470400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21558765","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000147-MRNA","pdf_url":"","pub_time":1785470400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/0001682852-26-000147-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/exhibit9912026q2pressrelea.htm","primary":true,"translateUrl":"","linkName":"exhibit9912026q2pressrelea.htm","type":"EX-99.1","id":"NTFILEGCQ5LR69kdJrKiub","market":"us","size":160093},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/mrna-20260731.htm","primary":false,"translateUrl":"","linkName":"mrna-20260731.htm","type":"8-K","id":"NTFILEB9pLp3XyeKcgahxW","market":"us","size":31056}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-07-31 12:00","pubTimestamp":1785470400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21536217","market":"us","labels":[],"media":"sec.gov","original_id":"AN108887526000046-MRNA","pdf_url":"","pub_time":1784902241000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"MRNA","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/0001088875-26-000046-index.html","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1088875/000108887526000046/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILE2YRSVzkgqdXuUt8e","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-07-24 22:10","pubTimestamp":1784902241,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21507130","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326005230-MRNA","pdf_url":"","pub_time":1784088000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管Hoge Stephen拟减持53,336股，总价约360万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326005230/0001959173-26-005230-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管Hoge Stephen拟减持53,336股，总价约360万美元","gpt_en_title":"Form 144 | Moderna's Officer Hoge Stephen proposes to sell 53,336 shares, with a total value of approximately $3.60 Million.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326005230/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE9xbFntPC8eVaV4Rv","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-07-15 12:00","pubTimestamp":1784088000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"21483617","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000134-MRNA","pdf_url":"","pub_time":1783483200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000134/0001682852-26-000134-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000134/exhibit991-07082026.htm","primary":true,"translateUrl":"","linkName":"exhibit991-07082026.htm","type":"EX-99.1","id":"NTFILE6N6Nj7z3R2eWAq4s","market":"us","size":11792},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000134/mrna-20260706.htm","primary":false,"translateUrl":"","linkName":"mrna-20260706.htm","type":"8-K","id":"NTFILE7KPCS8YViok27sPR","market":"us","size":33217}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-07-08 12:00","pubTimestamp":1783483200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21411729","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326004772-MRNA","pdf_url":"","pub_time":1781755200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326004772/0001959173-26-004772-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1035440/000195917326004772/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE6j6nxNhZtvHUSnur","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-18 12:00","pubTimestamp":1781755200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21396377","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326004640-MRNA","pdf_url":"","pub_time":1781496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326004640/0001959173-26-004640-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326004640/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE4xRHmWLFM9HJeLQ4","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-15 12:00","pubTimestamp":1781496000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21357405","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326004339-MRNA","pdf_url":"","pub_time":1780545600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326004339/0001959173-26-004339-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326004339/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILECvzfXgo18ZnzCzgU","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-04 12:00","pubTimestamp":1780545600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21295827","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326003865-MRNA","pdf_url":"","pub_time":1779336000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326003865/0001959173-26-003865-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1400240/000195917326003865/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEJ8adBMuhkGbK15jH","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-05-21 12:00","pubTimestamp":1779336000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21267332","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326003623-MRNA","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna, Inc. 高管 Stephen Hoge 拟减持53,336股普通股，拟套现约2,581,462.40美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326003623/0001959173-26-003623-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna, Inc. 高管 Stephen Hoge 拟减持53,336股普通股，拟套现约2,581,462.40美元","gpt_en_title":"Form 144 | Moderna, Inc. officer Stephen Hoge proposes to sell 53,336 shares of common stock, with an aggregate value of about $2,581,462.40","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326003623/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE4S3woWkHbwWf4hrW","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.modernatx.com;www.investors.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.0904},{"period":"1month","weight":1.3716},{"period":"3month","weight":2.0513},{"period":"6month","weight":1.6284},{"period":"1year","weight":4.6516},{"period":"ytd","weight":3.7586}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.112326},{"month":2,"riseRate":0.375,"avgChangeRate":0.016129},{"month":3,"riseRate":0.5,"avgChangeRate":0.01856},{"month":4,"riseRate":0.625,"avgChangeRate":0.096502},{"month":5,"riseRate":0.625,"avgChangeRate":0.057817},{"month":6,"riseRate":0.5,"avgChangeRate":0.038602},{"month":7,"riseRate":0.625,"avgChangeRate":0.066112},{"month":8,"riseRate":0.375,"avgChangeRate":0.116629},{"month":9,"riseRate":0.5,"avgChangeRate":-0.016602},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"aProfile":null}}}